Our mission is to bring forward new medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases.

South San Francisco, CA
Joined September 2011
We are happy to be a sponsor of #HCM9! If you are in Boston for this great event, we hope to see you on Saturday for our session covering the latest evidence in treating oHCM. Learn more in the conference agenda: bit.ly/4hMbDJ5 #HCMSummit #CardioTwitter
1
4
213
We are excited to be in Phoenix for the #HFSA2026. We look forward to seeing industry partners and making new connections. If you are here at , please stop by our booth #600. We can't wait to meet you! #HeartFailure #HCM #TeamCyto
1
6
274
Want to learn about how current research is evolving the way we think about the management of oHCM? Join us on today at #HFSA2026 for our Industry Theater event. #HeartFailure #Cardiology #HCM #CardioTwitter
2
200
We’re heading to the HFSA Annual Scientific Meeting in Phoenix! Come visit us at booth #600. #HFSA2026 #HeartFailure #HCM #Cardiology #CardioTwitter
2
1
3
233
We are excited to announce the launch of a new #research study that will generate important real-world insights to support clinicians in their everyday practice and treatment of adult patients with #oHCM. bit.ly/3TDmb3Z #Cardiology #CardioTwitter
2
1
5
573
We're excited to be attending #DGKHerztage. This event brings together leading cardiac experts, researchers, and clinicians from around the world to discuss the latest findings in the field of cardiovascular medicine. bit.ly/4y19bUb #DGK2026HT #CardioTwitter
1
124
We’re at ESC 2026 in Munich! Come visit us at booth #B200. #ESCCongress #WCCardio #CardioTwitter
2
277
$CYTK Investors: On August 28, at 2 p.m. CEST, we are hosting an in-person and virtual investor event live from #ESCCongress. Join us and featured HCM experts to hear more about late-breaking science presented at the Congress. #CardioTwitter
1
3
1,521
We're excited to be attending the #ESCCongress in #Munich. The event brings together experts from around the world to exchange knowledge about cardiovascular disease. We look forward to lively discussions on this timely topic. bit.ly/4iGszxI #CardioTwitter #Cardiology
175
We reported our Q2 earnings! Key highlights: - U.S. commercial momentum exceeding expectations - Germany product launch - advancements in our cardiology pipeline Everything we do is driven by a commitment to improving patient lives. bit.ly/4g4sl4u #Earnings
3
237
$CYTK: Today, we reported our second quarter 2026 financial results. Our senior management team will provide more details in a conference call at 4:30 p.m. ET. bit.ly/4583iIH #earnings #biopharma
5
754
Proud to see our President & CEO, Robert Blum, sharing his insights on @BW! Robert spoke about building a sustainable #biopharma company and why a national commitment to science is critical. #Cytokinetics
1
7
261
Thank you for sharing this, and a special thanks to Laura Pena for a fantastic presentation! Supporting and collaborating with scientists who are advancing our collective understanding of muscle biology is exactly why we put on this event. #CLIMB2026 #CardioTwitter
Laura Pena from our lab presenting her work today al #CLIMB. Hopefully out soon 👀. Exciting meeting on #cardiac and #skeletalmuscle pathophysiology, organized by @Cytokinetics. Sharing stage with big stars including @m_alexanian , @CardioOncology and @Rongtian2 .
1
2
384
Excited to see our President & CEO, Robert Blum, take the stage at #BiotechCEOSummit! He will lead a fireside chat on "The Purposeful CEO – Fulfilling the Promise," joining #biotech leaders in #NapaValley to discuss leadership, innovation and delivering for patients. #TeamCyto
🗓️ Joining us at the 11th Annual #BiotechCEOSummit, Robert Blum, President & CEO of @Cytokinetics, will lead our Fireside Chat: “The Purposeful CEO – Fulfilling the Promise.” We’re excited to welcome #biotech CEOs from around the world. 📍 July 13–15 | 🔗 biotechceosummit.com
1
3
207
This weekend, Cytokinetics is in Colorado for #ASE2026! Stop by booth 523 to explore the latest advancements in echocardiography. #CardioTwitter
1
116
Recently, we hosted the third annual #CLIMB26. Thank you to the presenters for sharing their innovative research and to the attendees from academia and industry for their commitment to the goal of advancing the understanding of muscle-related diseases and disorders.
1
119
New research in @JAMA_current! As a supporter of the #HCM registry, we are excited for these findings on improving risk prediction of adverse events in HCM patients. Read more: bit.ly/42wbzF1 #CardioX
2
3
397
We had an incredible time at #HeartFailure2026! It was a privilege to connect with leading experts, clinicians, and advocates from around the world. We are proud to be growing our European team to further support this vital community that continues to inspire our mission.
1
3
164
Attending #HeartFailure2026 in #Barcelona? Visit us at the Cytokinetics booth to talk with our team and learn more about our research & science. We'll be presenting data, sharing abstracts, and leading a sponsored satellite symposium. #HeartFailure #CardioX
1
1
5
227
We're excited to be attending ANMCO 2026 May 7–9 in Rimini, Italy. We'll be connecting with the Italian cardiology community at this congress dedicated to sharing knowledge and innovative perspectives. #ANMCO #CardioX
3
139